Scholay

学术搜索 · AI 审稿 · LaTeX 协作

T cell receptor activation contributes to brain damage after intracerebral hemorrhage in mice

作者:Yuwen Xiu, Yingjie Wang, Ningning Wang, Ning Liu, Yinghua Jiang, Mengxuan Shi, Di Zhou, Thin Yadanar Sein, Mitchell D. Kilgore, Prasad V. G. Katakam, Qiang Liu, Wei-Na Jin, Fu‐Dong Shi, Xiaoying Wang, Aaron S. Dumont · 发表于:Journal of Neuroinflammation · 年份:2025 · DOI:10.1186/s12974-025-03402-w · 被引用次数:9 · 研究领域:Intracerebral and Subarachnoid Hemorrhage Research、Neuroinflammation and Neurodegeneration Mechanisms、Intracranial Aneurysms: Treatment and Complications

BACKGROUND: Our previous studies demonstrated that activated T cells accumulate in perihematomal regions following intracerebral hemorrhage (ICH) and exacerbate hemorrhagic brain injury. In the present study, we aimed to explore the mechanisms underlying brain-infiltrating T cell activation and the associated pathophysiological effects in neurological outcomes following ICH. METHODS: We employed standardized collagenase injection-induced and autologous blood injection models of ICH in male C57BL/6J mice. T cell receptor (TCR) activation, immune cell infiltration, and cytokine production were quantified through immunostaining, flow cytometry, and cytokine arrays at 1- and 3-days post-ICH. Brain edema volume was measured at 3 days post-ICH and neurobehavioral assessments were conducted up to 14 days post-ICH. Pharmacological inhibition of TCR activation was achieved using the TCR-specific inhibitor AX-024, administered intraperitoneally at a dosage of 10 mg/kg 1-hour post-ICH. RESULTS: Flow cytometry and immunostaining detected TCR activation of brain-infiltrating T cells. Specific TCR activation inhibitor AX-024 administration markedly reduced TCR activation and the production of pro-inflammatory cytokines in the brain at 1- and 3-days post-ICH. Moreover, AX-024 administration led to a significant reduction in the infiltration of other leukocyte populations, and significantly reduced brain edema while improved long-term sensorimotor and cognitive outcomes up to 14 days post-IC...